RPG Life Sciences Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Sep ' 23	Sep ' 22	Mar ' 22	Sep ' 21	Sep ' 20

Sales

301.36

263.72

219.38

220.78

188.78

Operating profit

69.53

57.57

37.61

48.75

35.97

Interest

0.17

0.19

0.22

0.30

0.54

Gross profit

73.00

59.83

39.26

49.57

35.92

EPS (Rs)

29.00

23.09

13.39

17.74

12.22

Other income

3.64

2.45

1.87

1.12

0.49

Stock adjustment

-2.62

-0.93

-17.72

-7.49

-8.84

Raw material

67.77

43.44

48.27

39.86

45.94

Power and fuel

-

-

-

-

-

Employee expenses

66.38

55.00

50.60

49.37

47.49

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

100.30

108.64

100.62

90.29

68.22

Provisions made

-

-

-

-

-

Depreciation

8.44

7.70

7.71

7.95

8.36

Taxation

16.60

13.95

9.40

12.29

7.35

Net profit / loss

47.96

38.18

22.15

29.33

20.21

Extra ordinary item

-

-

-

-

-

Prior year adjustments

-

-

-

-

-

Equity capital

13.23

13.23

13.23

13.23

13.23

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

23.07

21.83

17.14

22.08

19.05

GPM (%)

23.93

22.48

17.74

22.34

18.98

NPM (%)

15.72

14.34

10.01

13.22

10.68